OTC Pharmaceuticals in the United States industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry.

This report provides a detailed analysis of the leading players and discusses how they are planning to sustain growth over the next five years.

The total RNAi therapy market is estimated to value $580m by 2012. This forecast is based upon current treatments, levels of market satisfaction and five new Phase II/III RNAi agents profiled in this report.

OTC Pharmaceuticals in Europe industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry.

This report explores the major types of adaptive design and their role in dose-finding. The report investigates seamless Phase 2/3 trials and adaptive trials in pharmacogenomics, assesses the logistical implications of adaptive trial implementations an

A review of the key events and trends shaping the pharmaceutical industry during 2007, with analysis of the future impact on the global pharmaceutical market in 2008 and beyond.

Overview of Datamonitor’s 2007 Pharmaceutical Technology research agenda and the key trends that will shape the pharmaceutical technology market in 2007.

Pharmaceuticals in Singapore industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry.

The purpose of this report is to describe the specific market segment of the diagnostics market called personalized medicine.

Pharmaceuticals in Canada industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry.

Microdosing (Phase 0 Trials), adaptive trials, phase IV trials and the role of information technology

OTC Pharmaceuticals in Spain industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry.

This report provides a complete insight into the Indian medical tourism market. It evaluates the past, present and future scenario of the Indian medical tourism market and discusses the key factors which are making India a favorable medical tourism des

OTC Pharmaceuticals in Belgium industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry.

Streamlining product development processes is becoming a major priority for pharmaceutical manufacturers looking to improve their market share, and respond to growing regulatory pressure and competition. This Datamonitor model forecasts the IT opportun

This report provides a detailed assessment of recent developments and future opportunities for biomarker companies in all major therapeutic areas.

Pharmaceuticals in the United States industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry.

The growth of emerging pharmaceutical markets remains impressively buoyant, having attained a 14.7% value increase over the 2005-06 period, a substantially greater rate than those witnessed within the developed markets of the EU and US.

Pharmaceuticals in Germany industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry.

Global Pharmaceuticals industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry.

The global pharmaceutical market is expected to earn over a trillion dollar in revenues by 2012

OTC Pharmaceuticals in Germany industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry.

In 2006, Pfizer’s Lipitor (atorvastatin) generated global revenues of $13.6bn, making it the best selling drug in pharmaceutical history. The blockbuster medicine has single-handedly driven the overall revenue margins of the cardiovascular segmen

An analysis of Argentina and Mexico, exploring the macroeconomic factors and pharmaceutical market dynamics. Despite their respective challenges, these two emerging markets are booming and represent an opportunity for foreign multinational firms.

As the shift towards translational research continues, the pharmaceutical industry is accelerating its spending on business intelligence (BI). This Datamonitor report forecasts and analyzes the IT opportunity for vendors serving the Big Pharma and Biot

The aim of this report is to provide in-depth information on the developing market for anti-cancer products and services.

Pharmaceuticals in Spain industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry.

This latest report explains just how this market will experience growth over the medium term future. Also do you know what the drivers and restraints of the market are? This report not only reveals these, but also details what strategies can be used to

Pharmaceuticals in China industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry.